|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Sienna Biopharmaceuticals, Inc. (SNNA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Wed 11/22
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
19,931,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.0001 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sienna Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s primary product candidates from its technological platform are SNA-120 (pegcantratinib), a first-in-class TrkA inhibitor for the topical treatment of psoriasis, as well as the associated pruritus; and SNA-125, a topical JAK3/TrkA inhibitor with the potential to treat various inflammatory conditions, including atopic dermatitis, psoriasis and the associated pruritus. Co.'s second technology platform, Topical Photoparticle Therapy™, utilizes silver particles applied to the skin to direct the light from commercially available lasers to the hair follicle or sebaceous gland to cause selective photothermolysis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Azoy Alexander |
Chief Financial Officer |
• – – |
2019-10-02 |
4 |
D |
$0.23 |
$551 |
D/D |
(2,396) |
103,552 |
|
- |
|
| Beddingfield Iii Frederick |
President & CEO |
• • – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
967,599 |
|
- |
|
| Azoy Alexander |
Chief Financial Officer |
• – – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
105,948 |
|
- |
|
| Andrews Timothy K. |
General Counsel & Secretary |
• – – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
145,558 |
|
- |
|
| Lizzul Paul F. |
Chief Medical Officer |
• – – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
196,488 |
|
- |
|
| Lizzul Paul F. |
Chief Medical Officer |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$3,112 |
D/D |
(4,095) |
141,488 |
|
- |
|
| Azoy Alexander |
Chief Financial Officer |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$1,180 |
D/D |
(1,552) |
35,948 |
|
- |
|
| Beddingfield Iii Frederick |
President & CEO |
• • – |
2019-07-02 |
4 |
D |
$0.76 |
$12,968 |
D/D |
(17,063) |
817,599 |
|
- |
|
| Stroehmann Diane |
See Remarks |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$3,112 |
D/D |
(4,095) |
168,545 |
|
- |
|
| Andrews Timothy K. |
General Counsel & Secretary |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$3,112 |
D/D |
(4,095) |
95,558 |
|
- |
|
| Azoy Alexander |
Chief Financial Officer |
• – – |
2019-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,500 |
|
- |
|
| Azoy Alexander |
Chief Financial Officer |
• – – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,500 |
|
- |
|
| Nelsen Robert |
10% Owner |
– – • |
2019-02-22 |
4 |
B |
$2.50 |
$5,414,500 |
I/I |
2,165,800 |
1,865,800 |
1.5 |
- |
|
| Burow Kristina |
Director |
– • – |
2019-02-22 |
4 |
B |
$2.50 |
$5,414,500 |
I/I |
2,165,800 |
1,865,800 |
2.1 |
- |
|
| More Robert J |
|
– • – |
2019-02-22 |
4 |
B |
$2.50 |
$250,000 |
D/D |
100,000 |
255,942 |
0.01 |
- |
|
| Beddingfield Iii Frederick |
President & CEO |
• • – |
2019-02-22 |
4 |
B |
$2.50 |
$100,000 |
D/D |
40,000 |
831,662 |
0.01 |
- |
|
| Leonard Keith R |
|
– • – |
2019-02-22 |
4 |
B |
$2.50 |
$250,000 |
D/D |
100,000 |
100,000 |
0.01 |
- |
|
| Gillis Steven |
10% Owner |
– – • |
2019-02-22 |
4 |
B |
$2.50 |
$5,414,500 |
I/I |
2,165,800 |
1,865,800 |
1.5 |
- |
|
| Beddingfield Iii Frederick |
President & CEO |
• • – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
187,500 |
791,662 |
|
- |
|
| Lizzul Paul F. |
Chief Medical Officer |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
142,583 |
|
- |
|
| Andrews Timothy K. |
General Counsel & Secretary |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
99,653 |
|
- |
|
| Smither John W |
Chief Financial Officer |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
46,657 |
|
- |
|
| Stroehmann Diane |
See Remarks |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
172,640 |
|
- |
|
| Beddingfield Iii Frederick |
President & CEO |
• • – |
2018-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
47,594 |
601,246 |
|
- |
|
| Harris Todd |
Head of Corporate Development |
• • – |
2018-04-30 |
4 |
AS |
$20.00 |
$2,000 |
D/D |
(100) |
570,991 |
|
- |
|
61 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
